These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1248 related articles for article (PubMed ID: 8572901)
1. Experimental antitumor activity and toxicity of the selected triazolo- and imidazoacridinones. Kuśnierczyk H; Chołody WM; Paradziej-Lukowicz J; Radzikowski C; Konopa J Arch Immunol Ther Exp (Warsz); 1994; 42(5-6):415-23. PubMed ID: 8572901 [TBL] [Abstract][Full Text] [Related]
2. Pharmacological and toxicological aspects of new imidazoacridinone antitumor agents. Berger B; Marquardt H; Westendorf J Cancer Res; 1996 May; 56(9):2094-104. PubMed ID: 8616856 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of DMP 840: a novel bis-naphthalimide cytotoxic agent with human solid tumor xenograft selectivity. McRipley RJ; Burns-Horwitz PE; Czerniak PM; Diamond RJ; Diamond MA; Miller JL; Page RJ; Dexter DL; Chen SF; Sun JH Cancer Res; 1994 Jan; 54(1):159-64. PubMed ID: 8261436 [TBL] [Abstract][Full Text] [Related]
4. A new antitumour agent, batracylin, selected by a preclinical solid tumour model. Atassi G; Dumont P; Kabbe HJ; Yoder O Drugs Exp Clin Res; 1988; 14(9):571-4. PubMed ID: 3229319 [TBL] [Abstract][Full Text] [Related]
5. Antitumor activity and mechanism of action of the novel marine natural products mycalamide-A and -B and onnamide. Burres NS; Clement JJ Cancer Res; 1989 Jun; 49(11):2935-40. PubMed ID: 2720652 [TBL] [Abstract][Full Text] [Related]
6. Comparative evaluation of toxicity and antitumor activity of original and reproduced anthracycline drugs. Kuśnierczyk H; Radzikowski C; Górecki P; Cichocka K Arch Immunol Ther Exp (Warsz); 1994; 42(1):51-62. PubMed ID: 7503636 [TBL] [Abstract][Full Text] [Related]
7. Biological evaluation of mitoxantrone dihydrochloride synthesized by a new method. I. Acute toxicity and antitumor activity in mouse transplantable tumor systems. Matuszyk J; Kuśnierczyk H; Radzikowski C Arch Immunol Ther Exp (Warsz); 1989; 37(1-2):77-88. PubMed ID: 2619512 [TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of novel ailanthone derivatives in vitro and in vivo. Kato T; Suzumura Y; Fukushima M; Honda T; Nakanishi T; Noguchi T Anticancer Res; 1988; 8(4):573-9. PubMed ID: 3178149 [TBL] [Abstract][Full Text] [Related]
9. [Antitumor effects of a new antitumor agent, zinostatin stimalamer (YM881)--effects on experimental tumors in vitro and in vivo]. Numasaki Y; Takahashi K; Masuda E; Nohara C; Maeda H Gan To Kagaku Ryoho; 1991 Oct; 18(13):2289-94. PubMed ID: 1834021 [TBL] [Abstract][Full Text] [Related]
10. Antitumor efficacy of PD115934 (NSC 366140) against solid tumors of mice. LoRusso P; Wozniak AJ; Polin L; Capps D; Leopold WR; Werbel LM; Biernat L; Dan ME; Corbett TH Cancer Res; 1990 Aug; 50(16):4900-5. PubMed ID: 2165850 [TBL] [Abstract][Full Text] [Related]
11. Marked antitumor activity of a new potent acronycine derivative in orthotopic models of human solid tumors. Guilbaud N; Kraus-Berthier L; Meyer-Losic F; Malivet V; Chacun C; Jan M; Tillequin F; Michel S; Koch M; Pfeiffer B; Atassi G; Hickman J; Pierré A Clin Cancer Res; 2001 Aug; 7(8):2573-80. PubMed ID: 11489841 [TBL] [Abstract][Full Text] [Related]
13. 1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-(methylamino)carbonylhydrazine (101M): a novel sulfonylhydrazine prodrug with broad-spectrum antineoplastic activity. Finch RA; Shyam K; Penketh PG; Sartorelli AC Cancer Res; 2001 Apr; 61(7):3033-8. PubMed ID: 11306484 [TBL] [Abstract][Full Text] [Related]
14. [Antitumor activity of polyanion and its application for drug delivery system of antitumor drugs]. Hirano T; Ohashi S; Todoroki T; Inaba M; Tsukagoshi S Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 2):542-7. PubMed ID: 2138872 [TBL] [Abstract][Full Text] [Related]
15. Rational design, synthesis, and in vivo evaluation of the antileukemic activity of six new alkylating steroidal esters. Koutsourea AI; Fousteris MA; Arsenou ES; Papageorgiou A; Pairas GN; Nikolaropoulos SS Bioorg Med Chem; 2008 May; 16(9):5207-15. PubMed ID: 18353651 [TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of imidazothioxanthones in murine and human tumor models in vitro and in vivo. Varvaresou A; Iakovou K; Gikas E; Fichtner I; Fiebig HH; Kelland LR; Double JA; Bibby MC; Hendriks HR Anticancer Res; 2004; 24(2B):907-19. PubMed ID: 15161044 [TBL] [Abstract][Full Text] [Related]
17. Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue. Bissery MC; Guénard D; Guéritte-Voegelein F; Lavelle F Cancer Res; 1991 Sep; 51(18):4845-52. PubMed ID: 1680023 [TBL] [Abstract][Full Text] [Related]
18. Potentiation of the antitumor activity by a novel quinoline compound, MS-209, in multidrug-resistant solid tumor cell lines. Nakanishi O; Baba M; Saito A; Yamashita T; Sato W; Abe H; Fukazawa N; Suzuki T; Sato S; Naito M; Tsuruo T Oncol Res; 1997; 9(2):61-9. PubMed ID: 9167187 [TBL] [Abstract][Full Text] [Related]
19. Synthesis of 9-O-substituted derivatives of 9-hydroxy-5, 6-dimethyl-6H-pyrido[4,3-b]carbazole-1-carboxylic acid (2-(dimethylamino)ethyl)amide and their 10- and 11-methyl analogues with improved antitumor activity. Guillonneau C; PierréA ; Charton Y; Guilbaud N; Kraus-Berthier L; Léonce S; Michel A; Bisagni E; Atassi G J Med Chem; 1999 Jun; 42(12):2191-203. PubMed ID: 10377224 [TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of idarubicin, a derivative of daunorubicin, against drug sensitive and resistant P388 leukemia. Tsuruo T; Oh-Hara T; Sudo Y; Naito M Anticancer Res; 1993; 13(2):357-61. PubMed ID: 8517647 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]